ReviewAging and disease2025
Correlations between Aging, Telomeres, and Natural Compounds.
Review in Aging and disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aging constitutes a complex biological phenomenon that is shaped and modulated by a wide range of genetic, metabolic, and environmental factors. A key characteristic of aging is the progressive shortening of telomeres, a process worsened by both physical and mental stressors. This shortening is interdependent with oxidative imbalance, persistent low-level inflammation, mitochondrial decline, and defective DNA repair mechanisms, factors that collectively drive age-associated disorders. Our review highlights the role of telomeres in the aging process. It examines the therapeutic potential of varied natural compounds, including flavonoids, carotenoids, peptides, polysaccharides, essential oils, and postbiotics in modulating these age-associated pathways. Experimental findings suggest that such compounds may safeguard telomeres, diminish oxidative injury, stabilize inflammatory signaling, and support mitochondrial bioenergetics. The convergence of findings from molecular, cellular, and in vivo studies supports the notion that integrating such compounds into both therapeutic and preventive dietary strategies may not only contribute to prolonged lifespan but also significantly enhance healthspan, the portion of life spent in good physical and cognitive health. However, the complex nature of aging pathways means that these promising insights also emphasize the importance of multidisciplinary research, which is indispensable for validating efficacy in clinical settings and exploring synergistic effects. Thorough human studies evaluating dosage, bioavailability, long-term safety, and population-specific effects are necessary to translate encouraging in vitro and animal findings into safe and effective interventions. The integrated examination of telomere biology and six classes of natural compounds along three main mechanistic axes-mitochondrial function, inflammatory modulation, and telomere maintenance-with a focus on translational relevance, is what makes this review novel. The dynamic relationship between telomere biology and naturally derived bioactive substances offers an interesting direction for low-risk interventions aimed at promoting healthy aging and reducing the global burden of age-related diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.